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Objectives. We sought to ascertain the utility of adenosine
thallium-201 tomography for assessing graft stenoses late after
coronary artery bypass graft surgery.
Background. Although pharmacologic perfusion imaging has
been increasingly used in the assessment of patients with coronary
artery disease, the value of this stress modality for detecting
coronary artery bypass graft stenosis late after surgery is un-
known.
Methods. We studied 109 patients who underwent both adeno-
sine thallium-201 tomography and coronary angiography at 6.7 6
4.8 (mean 6 SD) years after coronary artery bypass graft surgery.
Adenosine thallium-201 tomography was assessed quantitatively
by computer-generated polar maps of the myocardial thallium-
201 activity.
Results. On coronary angiography, significant graft stenoses
were present in 68 patients, 65 of whom had a corresponding
perfusion defect as shown by thallium-201 tomography (sensitivity
96%). Significant stenoses were present in 107 (37.8%) of 283
grafts. The overall specificity by quantitative tomography was
61%. Seventy percent of the apparently false positive perfusion
defects could be explained on the basis of unbypassed native
disease or by the presence of fixed defects in patients with
previous myocardial infarction.
Conclusions. Thus, results of adenosine thallium-201 tomogra-
phy are nearly always abnormal in patients with late coronary
graft stenosis. Most of the false positive defects appear to be due
to either unbypassed native disease or a previous myocardial
infarction.
(J Am Coll Cardiol 1997;29:1290–5)
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In the last few years, myocardial perfusion scintigraphy in
combination with pharmacologic stress has gained widespread
acceptance. Adenosine scintigraphy has been recently used in
the diagnosis of coronary artery disease (1–5) and shown to be
safe, sensitive and specific for detecting coronary stenoses
(2,3,5–7). In addition, it is a promising technique for risk
stratification before major operations (8) and in the early risk
stratification of patients who had a myocardial infarction (9).
Several investigators have used exercise thallium-201 scin-
tigraphy to assess graft patency after coronary artery bypass
graft surgery (10–17). Most of these studies were done rela-
tively early after the operation, and in many of them the goal
was to demonstrate improvement in myocardial perfusion
rather than the graft patency status. Graft patency is high early
after the operation but decreases with time, especially 5 years
or more after the operation. To date, there have been no
reports on the use of adenosine thallium scintigraphy—or, for
that matter, of any other pharmacologic stress—in the nonin-
vasive assessment of coronary graft patency. Accordingly, we
investigated the utility of adenosine thallium-201 tomography
to assess the patency status of grafts late after bypass surgery.
Methods
Between July 1, 1988 and December 31, 1993, 271 patients
underwent adenosine thallium tomography at least 1 year after
coronary artery bypass graft surgery at The Methodist Hospi-
tal. Among those patients, 109 (80 men and 29 women, mean
[6SD] age 66 6 9.2 years) also had a cardiac catheterization
within 3 months of cardiac scintigraphy and constitute the
study cohort. No intervening events occurred during this
interval. Adenosine scintigraphy was performed 6.7 6 4.8
(mean 6 SD) years after bypass surgery.
The indications for adenosine tomography included evalu-
ation of atypical (n 5 37) or typical (n 5 24) angina pectoris,
shortness of breath (n 5 17) and other reasons, including a
history of syncope, dizziness and referral for periodic check-up
in 31 patients. Sixty-seven patients (61%) had a history of
myocardial infarction and 25 patients had undergone coronary
angioplasty previously.
Adenosine thallium-201 tomography. Adenosine was ad-
ministered at a dose of 140 mg/kg body weight per min for a
total of 6 min into a peripheral antecubital vein using a
pump-controlled infusion system. With this infusion protocol,
maximal hyperemia is achieved by 84 6 46 s (18). At 3 min into
the adenosine infusion, 3 mCi of thallium-201 was injected as
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a bolus in a contralateral vein and rapidly flushed with 10 ml of
normal saline. A 3-lead electrocardiogram (ECG) was contin-
uously monitored throughout the infusion of adenosine. Vital
signs and a 12-lead ECG were obtained every minute during
the infusion and for 5 min after completion of the adenosine
administration.
Tomographic imaging was performed immediately after
discontinuation of the adenosine infusion and redistribution
images were obtained 4 h later. Image acquisition was per-
formed using a large field-of-view, single-crystal, rotating
gamma camera (ADAC ARC 3000-3300) equipped with a high
resolution, parallel-hole collimator with a septal length and
thickness of 33 and 0.15 mm, respectively. Image acquisition
was performed over a 180° arc, at 6° intervals, for 40 s per
frame. Reconstruction used a back-projection technique with a
Butterworth (order of 5, 50% cutoff) high pass filter and a low
pass window. Reconstructed tomographic slices of 6 mm in
thickness were then reoriented into the standard short, hori-
zontal long and vertical long axes for quantitative analysis.
The reconstructed slices were reviewed without prior
knowledge of the angiographic findings. The studies were
analyzed both qualitatively and quantitatively. Anterior, an-
teroseptal, anterolateral and anteroapical segments subtended
the left anterior descending vascular territory; inferior, poste-
rior and posteroapical segments comprised the right coronary
artery territory; and lateral and posterolateral segments com-
prised the circumflex territory.
The thallium-201 tomographic images were quantified us-
ing computerized two-dimensional polar maps of the three-
dimensional myocardial radioactivity. Both stress and redistri-
bution maps were generated independently and normalized
through the use of standard circumferential profile analysis.
Stress and redistribution polar maps for each patient were
compared with an adenosine normal data base map previously
generated in our laboratory. This normal data base consists of
50 individuals who were at low risk for coronary artery disease
and had visually normal tomograms (19). A pixel count-activity
in the patients’ initial polar map was considered abnormal if it
was more than 2.5 SD below the mean count-activity for the
corresponding pixel in the normal data base. Furthermore, a
pixel in the redistribution polar map was considered abnormal
if its activity increased by more than 2.5 SD above the mean
count-activity for the corresponding pixel in the normal data
base. Quantification of the initial perfusion defect size, as well
as the extent of redistribution, was then expressed as a
percentage of abnormal pixels within the initial and redistri-
bution polar maps, as previously described from our laboratory
(19,20). After comparison between the stress and redistribu-
tion studies, defects were categorized as ischemic (when
reversible), scar (if fixed) or mixed.
Coronary angiography. Selective cine coronary angiogra-
phy was performed in multiple views with standard techniques.
The native coronary circulation, as well as the bypass grafts,
was selectively opacified. The presence of collateral circulation
to stenotic vessels was noted. Stenoses were measured using
electronic calipers by an experienced angiographer who had no
knowledge of the scintigraphic data. Results were expressed as
percent lumen diameter stenosis. Lesion severity was graded as
follows: normal (,25% lumen diameter stenosis), insignificant
(26% to 50%), moderate (51% to 69%) and severe ($70%).
This grading system was applied to both the native coronary
circulation and to the grafts. Graft patency was defined by
absence of significant ($70%) stenosis, irrespective of the
status of the native circulation proximal or distal to the graft
anastomosis. A graft was considered to be occluded if a stump
was clearly demonstrated in the aortic root or if the graft was
not visualized after contrast aortography. The number of grafts
placed during the operation was obtained from the operative
reports. The left ventricular ejection fraction (which was
measured in 88 patients) and the presence and location of wall
motion abnormalities were assessed by contrast ventriculogra-
phy.
Statistical analysis. Sensitivity was defined as the number
of true positive scans (3100) divided by the true positive plus
false negative scans. Specificity was defined as the number of
true negative scans (3100) divided by the number of true
negative plus false positive scans.
Results
Extent of coronary artery disease and left ventricular
function. Native triple-vessel coronary artery disease occurred
in 63 patients (58%), followed by single- or double-vessel
disease in 24 patients (22%) and left main stenosis in 22
patients (20%). Fifty-four patients (50%) had collateral vessels
to the stenosed arteries. The left ventricular ejection fraction
was 49 6 14% (range 15% to 75%).
Detection of graft stenosis by thallium tomography. There
were 283 bypass grafts, 40 of which were internal mammary
conduits (Table 1). Sixty-eight of the total 109 patients had one
or more stenotic bypass grafts. Sixty-five of these patients had
a perfusion abnormality as shown by thallium-201 tomography
Table 1. Baseline Characteristics of 109 Study Patients
Male 80
Age (yr) 66 6 9.2
Previous myocardial infarction 67
Reasons for study
Typical chest pain 24
Atypical chest pain 37
Shortness of breath 17
Other 31
Left ventricular ejection fraction 49 6 14
Native coronary disease
Triple vessel 63 (58%)
LMCA 22 (20%)
One or two vessel 24 (22%)
Total number of grafts 283 (100%)
Saphenous grafts 243 (86%)
Internal mammary graft 40 (14%)
Data presented are mean value 6 SD or number (%) of patients. LMCA 5
left main coronary artery.
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(overall sensitivity 96%). The mean perfusion defect size on
tomography was 23 6 17% of the left ventricle (range 5% to
65%). Figure 1 shows a patient with graft stenosis 6 years after
bypass surgery. The types of perfusion abnormalities observed
are summarized in Table 2. The majority (85%) of the
perfusion defects were totally or partially reversible during
redistribution imaging. The overall specificity by quantitative
tomography was 61%.
Reasons for false positive thallium tomograms. A careful
review of all false positive results was made in an attempt to
identify conditions that might have resulted in myocardial
hypoperfusion, despite angiographically patent grafts, such as
unbypassed native disease proximal or distal to patent grafts,
and fixed defects (from a previous myocardial infarction).
Two-thirds (47 of 70) of our apparent false positive perfusion
defects were explained on the basis of unbypassed native
disease proximal or distal to patent grafts (n 5 25) or the
presence of fixed defects corresponding to the site of ECG Q
waves in patients with a previous infarction (n 5 22). One such
example is illustrated in Figure 2.
Discussion
Throughout the last decade, revascularization procedures
for the treatment of coronary artery disease have continued to
proliferate. It is estimated that over 400,000 coronary artery
bypass graft surgeries are performed in the United States each
year. Long-term graft patency is the major factor limiting the
initial clinical benefits of revascularization and patient survival.
Although cardiac catheterization remains the reference stan-
dard for graft patency, it is not totally risk free, and it is
expensive. In addition, after bypass surgery many patients may
have chest pains that are unrelated to myocardial ischemia.
Thallium scintigraphy allows the assessment of these patients
serially after the operation and the identification of those with
perfusion defects which, on the basis of their extent, the
vascular territories involved and reversibility as well as perti-
nent clinical history, should undergo invasive evaluation and
subsequent repeat revascularization.
Figure 1. Adenosine single-photon emission computed tomographic
study of a patient who underwent coronary artery bypass graft surgery
6 years earlier. The tomographic slices are displayed in the short-axis
(top two rows), horizontal long-axis (middle two rows) and vertical
long-axis (bottom two rows) views. The top row of each pair represents
the adenosine images and the bottom row the 4-h redistribution
images. Also displayed are the corresponding polar maps depicting the
extent of fixed (black) and reversible (green) defects (top panel), the
intensity of the defect (amber for moderate and green for severe
thallium-201 uptake reduction) (middle panel) and the completeness
of redistribution (amber for $70%, green .50% to ,70%) (lower
panel). Predominantly reversible defects are seen in the posterolateral
segments (circumflex territory) and posterior wall (right coronary
territory) and a small mixed defect is seen in the anteroapical segment
(left anterior descending territory). Contrast angiography showed 90%
stenosis of the obtuse marginal artery with an occluded saphenous
graft, a 100% occluded right coronary artery with an occluded saphe-
nous graft and a 100% proximal occlusion of the left anterior
descending coronary artery with a patent internal mammary graft but
95% stenosis distal to the graft anastomosis site. DLV 5 delayed (4 h)
imaging; STR 5 stress imaging.
1292 KHOURY ET AL. JACC Vol. 29, No. 6
ADENOSINE TOMOGRAPHY AFTER CORONARY SURGERY May 1997:1290–5
Perfusion scintigraphy for evaluating coronary graft pa-
tency. Despite the well demonstrated advantages of perfusion
scintigraphy for assessing regional myocardial perfusion, there
are very few published reports evaluating this technique in
patients with previous revascularization surgery, and most have
included relatively few patients. Because a substantial number
of patients referred for imaging cannot exercise or attain
maximal heart rates (20), and many patients continue to use
anti-ischemic medications after surgery, exercise testing is
often inadequate and has a negative impact on the sensitivity
of scintigraphy for detecting graft disease (21,22). Thus, phar-
macologic intervention may be advantageous in these patients.
In this study, we report our experience in a cohort of 109
patients studied late (average 6.7 years) after coronary artery
bypass graft surgery. The overall sensitivity by quantitative
tomographic analysis was 96%, with a specificity of 61%.
Previous reports on the utility of thallium scintigraphy for
assessing patients after bypass surgery were confined to exer-
cise stress scintigraphy. Furthermore, the majority of those
reports used planar imaging, which has important limitations
for detecting perfusion abnormalities and identifying the ana-
tomic location of the involved vascular territory. In their
experience with 20 patients undergoing planar thallium scin-
tigraphy, Ritchie et al. (17) reported a graft patency of 87% in
patients with no new perfusion defects, which fell to 54% in
patients with exercise-induced perfusion defects. Scholl et al.
(23) used planar scintigraphy within 3 months of bypass
surgery and were able to accurately predict the patency status
in 13 of 15 grafts. Wainwright et al. (24) studied a larger
patient cohort with exercise planar thallium scintigraphy an
average of 15 months after bypass surgery. The positive and
negative predictive accuracies for detecting patent or occluded
Figure 2. Adenosine thallium-201 single-photon emission computed
tomographic study performed in a patient who underwent coronary
artery bypass graft surgery 3 years earlier. The display is similar to that
described in Figure 1. The images show reversible posterolateral,
apical and anterior perfusion defects, consistent with ischemia in the
circumflex and left anterior descending territories. Contrast angiogra-
phy showed a patent left internal mammary graft to the second obtuse
marginal artery. However, a large unbypassed first obtuse marginal
artery had 90% proximal stenosis. The unbypassed left anterior
descending coronary artery had 50% proximal stenosis. The first
diagonal branch had 90% proximal stenosis with a patent right internal
mammary graft, which, however, had 90% stenosis at the anastomosis
site. The right coronary artery was normal. This case illustrates how
perfusion abnormalities may be caused by incomplete revasculariza-
tion despite a patent graft, on the one hand, and by graft stenosis, on
the other.




Normal 45 69 52
Reversible 11 8 22
Fixed 9 9 6
Mixed 44 23 29
LAD 5 left anterior descending coronary artery; LCx 5 left circumflex
coronary artery; RCA 5 right coronary artery.
1293JACC Vol. 29, No. 6 KHOURY ET AL.
May 1997:1290–5 ADENOSINE TOMOGRAPHY AFTER CORONARY SURGERY
grafts supplying noninfarcted myocardium were 85% and 81%,
respectively. Kureshi et al. (13) used tomographic imaging in
17 patients before and after bypass surgery. Their reported
graft patency rate was 78%, and all occluded grafts had a
reversible defect in the vascular territory corresponding to the
grafts. We have recently reported our experience with exercise
thallium tomography for evaluating coronary artery bypass
graft patency in 50 patients. The overall sensitivity for detect-
ing graft stenoses was 83%, with a specificity of 87% and a
predictive accuracy of 82% (25).
Possible reasons for discrepancy between scintigraphy and
graft patency. To the best of our knowledge, ours is the first
published report using adenosine thallium tomography to
assess the patency status of coronary bypass grafts. The
observed sensitivity for detecting graft stenosis is comparable
to the reported sensitivity for detecting stenosis in native
coronary arteries (22), as well as similar to the sensitivity of
exercise thallium tomography for detecting graft stenosis (25).
The somewhat low specificity found in our cohort was predi-
cated on the relatively frequent occurrence of myocardial
hypoperfusion in regions with patent grafts. These false posi-
tive scans fell under two major categories: the first included
patients with patent grafts supplying myocardium partly
scarred from a previous myocardial infarct. This evidently is a
reflection of the high frequency (61%) of previous myocardial
infarction in our study cohort. The second category resulted
from unbypassed native disease proximal to the grafts, or
progression of native disease distal to the grafts. This latter
category becomes increasingly important with longer survival
times after the operation. The remaining false positive defects
were likely caused by photon attenuation or reconstruction
artifacts. It is also possible that even some of the defects that
fell under the two mechanisms discussed above were also
caused by photon attenuation or reconstruction artifacts, or
that some of the grafts had functionally significant disease not
identified by angiography.
Restricting our analysis to patients without a previous
myocardial infarction without any unbypassed stenosis would
have limited the number of false positive scans. Nevertheless,
we were able to explain the majority of these apparently false
positive results on the basis of either a previous myocardial
infarction or nonrevascularized myocardial regions perfused by
arteries with patent grafts, but with unbypassed stenoses
proximal or distal to the graft anastomosis site.
Alternative noninvasive diagnostic techniques for the as-
sessment of graft stenosis. Ultrafast computed tomography
has been used for identifying coronary artery bypass graft
occlusion or patency with high success rates (26,27). However,
the differentiation between patent grafts with stenoses and
patent grafts without stenoses cannot be done reliably at the
present time. Magnetic resonance imaging has also been
recently used for the evaluation of coronary bypass grafts, but
it has a similar limitation as ultrafast computed tomography
with respect to identifying patent but stenotic grafts (28–30).
Positron emission tomography has been used predominantly in
the evaluation of myocardial viability before revascularization,
but not in the prediction of graft patency status after bypass
surgery, although flow studies with this technique could con-
ceivably be used for this purpose.
Exercise echocardiography has also been used after bypass
grafting (30–32). Sawada et al. (31) reported a sensitivity of
94% for the detection of “nonrevascularized” vessels, with a
specificity of 83%. In this study the majority of patients (35 of
42) had nonrevascularized vessels, and most of these patients
(n 5 20) had inadequate revascularization in multiple vascular
territories. The graft patency rate was not reported in this
study. Many patients had a previous myocardial infarction (n 5
19) and rest wall motion abnormalities, which may have
enhanced the sensitivity.
Crouse et al. (32) reported a sensitivity of exercise echo-
cardiography of 98%, with a specificity of 92% for detecting
“compromised regional vascular supply.” In this study, most
patients (112 of 125 patients) had compromised vascular
supply. The graft patency rate and number of patients with a
previous myocardial infarction and rest wall motion abnormal-
ities were not reported.
Kafka et al. (33) studied 182 patients after coronary bypass
grafting. These investigators found a positive predictive value
of 85% and negative predictive value of 81% for exercise
echocardiography. The graft patency rate and number of
patients with a previous myocardial infarction were not re-
ported. Thus, exercise echocardiography may also be useful for
evaluating patients after coronary bypass grafting. A potential
limitation of this technique, however, is the inability to clearly
distinguish between involvement of the right coronary and
circumflex artery vascular territories. Moreover, the ability of
this technique to detect graft patency or occlusion has not been
reported to date. It is likely that the ubiquitous presence of
septal wall motion abnormality after coronary bypass grafting,
coupled with difficulty in obtaining appropriate echocardio-
graphic windows immediately after exercise, may hamper the
echocardiographic interpretations.
Study limitations. The high frequency of previous myocar-
dial infarction in our patient cohort may have contributed to
the overall sensitivity as well as the sensitivity for detecting
individual graft stenosis. Unfortunately, our cohort was not
large enough to allow for a meaningful separate analysis of
patients with and without previous infarctions. This remains an
important limitation of our study.
Conclusions. Coronary artery bypass graft surgery is in-
creasingly being used in an older population that is often
unable to exercise adequately; therefore, it is time to validate
a noninvasive means for assessing graft patency. Adenosine
tomography appears to be a promising diagnostic tool with
good accuracy. Studies performed before and after the oper-
ation can best document the benefits of revascularization.
Most defects detected after bypass surgery represent either
graft disease, progression of disease in the native vessels,
pre-existing but unbypassed disease or scarring from a previous
myocardial infarction.
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